Literature DB >> 21264450

As many as 12 cases with haemorrhagic acquired factor XIII deficiency due to its inhibitors were recently found in Japan.

A Ichinose, M Souri.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21264450     DOI: 10.1160/TH10-11-0724

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  5 in total

Review 1.  Acquired FXIII inhibitors: a systematic review.

Authors:  Massimo Franchini; Francesco Frattini; Silvia Crestani; Carlo Bonfanti
Journal:  J Thromb Thrombolysis       Date:  2013-07       Impact factor: 2.300

Review 2.  Factor XIII is a key molecule at the intersection of coagulation and fibrinolysis as well as inflammation and infection control.

Authors:  Akitada Ichinose
Journal:  Int J Hematol       Date:  2012-04-05       Impact factor: 2.490

3.  Reduced difference of α₂-plasmin inhibitor levels between plasma and serum in patients with severe factor XIII deficiency, including autoimmune hemorrhaphilia due to anti-factor XIII antibodies.

Authors:  Akitada Ichinose; Masayoshi Souri
Journal:  Int J Hematol       Date:  2011-12-29       Impact factor: 2.490

4.  Successful bypass surgery for esophageal carcinoma under adequate factor XIII/13 replacement therapy in a case of intractable autoimmune hemorrhaphilia due to anti-Factor XIII/13 antibodies.

Authors:  Minoru Kojima; Akitada Ichinose; Masayoshi Souri; Tsukasa Osaki; Hidetsugu Kawai; Jun Amaki; Hiroki Numata; Mitsuki Miyamoto; Daisuke Ogiya; Kosuke Tsuboi; Yoshiaki Ogawa; Soji Ozawa; Kiyoshi Ando
Journal:  Int J Hematol       Date:  2015-11-30       Impact factor: 2.490

5.  Effects of Factor XIII Deficiency on Thromboelastography. Thromboelastography with Calcium and Streptokinase Addition is more Sensitive than Solubility Tests.

Authors:  M Martinuzzo; L Barrera; D Altuna; F Tisi Baña; J Bieti; Q Amigo; M D'Adamo; M S López; J Oyhamburu; J C Otaso
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-08-16       Impact factor: 2.576

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.